The effects of placental ischemia on blood pressure and many facets observed in preeclampsia can be alleviated by inhibition of T cells, either by blocking cells with antigen interacting with T cells, or by a deficiency Overall in T cells. Above all, these data suggest the potential use of anti-inflammatory drugs targeting T cell suppression as a therapy for preeclampsia. These studies highlight the importance of targeting CD4 + T cell suppression as a means of reducing blood pressure, cytokine production, anti-angiogenic factors, autoantibodies, and the resistive index of the uterine artery v to improve symptoms of preeclampsia in late pregnancy in PE women.
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Case Report: Journal of Blood & Lymph
Case Report: Journal of Blood & Lymph
Opinion: Journal of Blood & Lymph
Opinion: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Scientific Tracks Abstracts: Journal of Forensic Research
Scientific Tracks Abstracts: Journal of Forensic Research
Journal of Blood & Lymph received 443 citations as per Google Scholar report